Prof. Dr. Jan T. Kielstein

Publikationen

I Originalpublikationen Erst - und Letztautorenschaften / equally contributed

Schmidt JJ, Asper F, Einecke G, Eden G, Hafer C, Kielstein JT.
Therapeutic plasma exchange in a tertiary care center: 185 patients undergoing 912 treatments - a one-year retrospective analysis. 
BMC Nephrol. 2018; 19(1):12.

Hiller RG, Patecki M, Neunaber C, Reifenrath J, Kielstein JT, Kielstein H.
A comparative study of bone biopsies from the iliac crest, the tibial bone, and the lumbar spine. 
BMC Nephrol. 2017; 18(1):134.

Nemcsik J, Cseprekál O, Egresits J, Kielstein JT, Kümpers P, Lukasz A, Tabák Á, Marton A, Németh ZK, Járai Z, Godina G, Sallai L, Farkas K, Kiss I, Tislér A.
The role of laser Doppler flowmetry tests, serum angiopoietin-2, asymmetric and symmetric dimethylarginine to predict outcome in chronic kidney disease.
J Hypertens. 2017; 35(5):1109-1118.

Faulhaber-Walter R, Scholz S, Haller H, Kielstein JT, Hafer C.
Health status, renal function, and quality of life after multiorgan failure and acute kidney injury requiring renal replacement therapy. 
Int J Nephrol Renovasc Dis. 2016; 9:119-28.

Hafer C, Golla P, Gericke M, Eden G, Beutel G, Schmidt JJ, Schmidt BM, De Reys S, Kielstein JT.
Membrane versus centrifuge-based therapeutic plasma exchange: a randomized prospective crossover study. 
Int Urol Nephrol. 2016; 48(1):133-8.

Schmidt JJ, Jahn J, Golla P, Hafer C, Kielstein JT, Kielstein H.
Effect of therapeutic plasma exchange on plasma levels and total removal of adipokines and inflammatory markers. 
BMC Obes. 2015; 2:37.

Schneider SM, Malecki AK, Müller K, Schönfeld R, Girndt M, Mohr P, Hiss M, Kielstein H, Jäger K, Kielstein JT.
Effect of a single dialysis session on cognitive function in CKD5D patients: a prospective clinical study. 
Nephrol Dial Transplant. 2015; 30(9):1551-9.

Kielstein H, Suntharalingam M, Perthel R, Song R, Schneider SM, Martens-Lobenhoffer J, Jäger K, Bode-Böger SM, Kielstein JT.
Role of the endogenous nitric oxide inhibitor ADMA and BDNF in depression and behavioural changes: clinical and preclinical data in chronic kidney disease. 
Nephrol Dial Transplant. 2015;30(10):1699-705.

Hadem J, Hafer C, Schneider AS, Wiesner O, Beutel G, Fuehner T, Welte T, Hoeper MM, Kielstein JT.
Therapeutic plasma exchange as rescue therapy in severe sepsis and septic shock: retrospective observational single-centre study of 23 patients. 
BMC Anesthesiol. 2014; 14:24.

Schmidt JJ, Hafer C, Spielmann J, Hadem J, Schönenberger E, Schmidt BM, Kielstein JT.
Removal characteristics and total dialysate content of glutamine and other amino acids in critically ill patients with acute kidney injury undergoing extended dialysis. 
Nephron Clin Pract. 2014;126(1):62-6.

Lukasz A, Hoffmeister B, Graf B, Wölk B, Noeckler K, Bode-Böger SM, Hadem J, Pischke S, Kielstein JT.
Association of angiopoietin-2 and dimethylarginines with complicated course in patients with leptospirosis.
PLoS One. 2014;9(1):e87490.

Lukasz A, Beneke J, Menne J, Vetter F, Schmidt BM, Schiffer M, Haller H, Kümpers P, Kielstein JT.
Serum neutrophil gelatinase-associated lipocalin (NGAL) in patients with Shiga toxin mediated haemolytic uraemic syndrome (STEC-HUS).
Thromb Haemost. 2014; 111(2):365-72.

Tutarel O, Röntgen P, Bode-Böger SM, Martens-Lobenhoffer J, Westhoff-Bleck M, Diller GP, Bauersachs J, Kielstein JT.
Symmetrical dimethylarginine is superior to NT-proBNP for detecting systemic ventricular dysfunction in adults after atrial repair for transposition of the great arteries. 
Int J Cardiol. 2013; 168(4):4415-6.

 

II Originalpublikationen Co-Autorenschaften

Economou CJP, Kielstein JT, Czock D, Xie J, Field J, Richards B, Tallot M, Visser A, Koenig C, Hafer C, Schmidt JJ, Lipman J, Roberts JA.
Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy. 
Int J Antimicrob Agents. 2018; S0924-8579(18)30072-4.

Kölling M, Genschel C, Kaucsar T, Hübner A, Rong S, Schmitt R, Sörensen-Zender I, Haddad G, Kistler A, Seeger H, Kielstein JT, Fliser D, Haller H, Wüthrich R, Zörnig M, Thum T, Lorenzen J.
Hypoxia-induced long non-coding RNA Malat1 is dispensable for renal ischemia/reperfusion-injury. 
Sci Rep. 2018;8(1):3438.

Worthmann H, Li N, Martens-Lobenhoffer J, Dirks M, Schuppner R, Lichtinghagen R, Kielstein JT, Raab P, Lanfermann H, Bode-Böger SM, Weissenborn K.
Dimethylarginines in patients with intracerebral hemorrhage: association with outcome, hematoma enlargement, and edema. 
J Neuroinflammation. 2017; 14(1):247.

Ivanyi P, Beutel G, Drewes N, Pirr J, Kielstein JT, Morgan M, Ganser A, Grünwald V.
Therapy of Treatment-Related Hypertension in Metastatic Renal-Cell Cancer Patients Receiving Sunitinib 
Clin Genitourin Cancer. 2017;15(2):280-290.e3.

Nemcsik J, Cseprekál O, Egresits J, Kielstein JT, Kümpers P, Lukasz A, Tabák Á, Marton A, Németh ZK, Járai Z, Godina G, Sallai L, Farkas K, Kiss I, Tislér A.
The role of laser Doppler flowmetry tests, serum angiopoietin-2, asymmetric and symmetric dimethylarginine to predict outcome in chronic kidney disease. 
J Hypertens. 2017; 35(5):1109-1118.

Ivanyi P, Beutel G, Drewes N, Pirr J, Kielstein JT, Morgan M, Ganser A, Grünwald V.
Therapy of Treatment-Related Hypertension in Metastatic Renal-Cell Cancer Patients Receiving Sunitinib. 
Clin Genitourin Cancer. 2017;15(2):280-290.e3.

Beneke J, Sartison A, Kielstein JT, Haller H, Nitschke M, Kunzendorf U, Loos S, Kemper MJ, Stahl RA, Menne J; German 2011 STEC-HUS outbreak study group.
Clinical and Laboratory Consequences of Platelet Transfusion in Shiga Toxin-Mediated Hemolytic Uremic Syndrome. 
Transfus Med Rev. 2017; 31(1):51-55.

Sekula P, Li Y, Stanescu HC, Wuttke M, Ekici AB, Bockenhauer D, Walz G, Powis SH, Kielstein JT, Brenchley P; GCKD Investigators, Eckardt KU, Kronenberg F, Kleta R, Köttgen A.
Genetic risk variants for membranous nephropathy: extension of and association with other chronic kidney disease aetiologies. 
Nephrol Dial Transplant. 2017;32(2):325-332.

Busch M, Nadal J, Schmid M, Paul K, Titze S, Hübner S, Köttgen A, Schultheiss UT, Baid-Agrawal S, Lorenzen J, Schlieper G, Sommerer C, Krane V, Hilge R, Kielstein JT, Kronenberg F, Wanner C, Eckardt KU, Wolf G; GCKD Study Investigators.
Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease - cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort.
BMC Nephrol. 2016; 17(1):59.

Schuppner R, Maehlmann J, Dirks M, Worthmann H, Tryc AB, Sandorski K, Bahlmann E, Kielstein JT, Giesemann AM, Lanfermann H, Weissenborn K.
Neurological Sequelae in Adults After E coli O104: H4 Infection-Induced Hemolytic-Uremic Syndrome. 
Medicine (Baltimore). 2016;95(6):e2337.

Lukasz A, Beneke J, Thamm K, Kielstein JT, Menne J, Mikesch JH, Schmidt BM, Haller H, Kümpers P, David S, Schiffer M.
Involvement of Angiopoietin-2 and Tie2 Receptor Phosphorylation in STEC-HUS Mediated by Escherichia coli O104:H4. 
Mediators Inflamm. 2015; 2015:670248.

Reising A, Hafer C, Hiss M, Kielstein JT, Menne J, Gueler F, Beneke J, Linnenweber-Held S, Haller H, Einecke G.
Ultrasound findings in EHEC-associated hemolytic-uremic syndrome and their clinical relevance. 
Int Urol Nephrol. 2016;48(4):561-70.

Ius F, Sommer W, Kieneke D, Tudorache I, Kühn C, Avsar M, Siemeni T, Salman J, Erdfelder C, Verboom M, Kielstein JT, Tecklenburg A, Greer M, Hallensleben M, Blasczyk R, Schwerk N, Gottlieb J, Welte T, Haverich A, Warnecke G.
IgM-Enriched Human Intravenous Immunoglobulin-Based Treatment of Patients With Early Donor Specific Anti-HLA Antibodies After Lung Transplantation.
Transplantation. 2016; 100(12):2682-2692.

Hadem J, Gottlieb J, Seifert D, Fegbeutel C, Sommer W, Greer M, Wiesner O, Kielstein JT, Schneider AS, Ius F, Fuge J, Kühn C, Tudorache I, Haverich A, Welte T, Warnecke G, Hoeper MM.
Prolonged Mechanical Ventilation After Lung Transplantation-A Single-Center Study. 
Am J Transplant. 2016; 16(5):1579-87.

Sitar ME, Kayacelebi AA, Beckmann B, Kielstein JT, Tsikas D.
Asymmetric dimethylarginine (ADMA) in human blood: effects of extended haemodialysis in the critically ill patient with acute kidney injury, protein binding to human serum albumin and proteolysis by thermolysin. 
Amino Acids. 2015;47(9):1983-93.

Lorenzen JM, Schauerte C, Hübner A, Kölling M, Martino F, Scherf K, Batkai S, Zimmer K, Foinquinos A, Kaucsar T, Fiedler J, Kumarswamy R, Bang C, Hartmann D, Gupta SK, Kielstein JT, Jungmann A, Katus HA, Weidemann F, Müller OJ, Haller H, Thum T.
Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis.
Eur Heart J. 2015; 36(32):2184-96.

Ettinger M, Calliess T, Kielstein JT, Sibai J, Brückner T, Lichtinghagen R, Windhagen H, Lukasz A.
Circulating biomarkers for discrimination between aseptic joint failure, low-grade infection, and high-grade septic failure.
Clin Infect Dis. 2015; 61(3):332-41.

Ghosh CC, Thamm K, Berghelli AV, Schrimpf C, Maski MR, Abid T, Milam KE, Rajakumar A, Santel A, Kielstein JT, Ahmed A, Thickett D, Wang K, Chase M, Donnino MW, Aird WC, Haller H, David S, Parikh SM.
Drug Repurposing Screen Identifies Foxo1-Dependent Angiopoietin-2 Regulation in Sepsis. 
Crit Care Med. 2015; 43(7):e230-40.

Ius F, Sommer W, Tudorache I, Kühn C, Avsar M, Siemeni T, Salman J, Hallensleben M, Kieneke D, Greer M, Gottlieb J, Kielstein JT, Boethig D, Welte T, Haverich A, Warnecke G.
Preemptive treatment with therapeutic plasma exchange and rituximab for early donor-specific antibodies after lung transplantation. 
J Heart Lung Transplant. 2015; 34(1):50-8.

Jing J, Kielstein JT, Schultheiss UT, Sitter T, Titze SI, Schaeffner ES, McAdams-DeMarco M, Kronenberg F, Eckardt KU, Köttgen A; GCKD Study Investigators.
Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: the German Chronic Kidney Disease (GCKD) study. 
Nephrol Dial Transplant. 2015; 30(4):613-21.

Lorenzen JM, Schauerte C, Kielstein JT, Hübner A, Martino F, Fiedler J, Gupta SK, Faulhaber-Walter R, Kumarswamy R, Hafer C, Haller H, Fliser D, Thum T.
Circulating long noncoding RNATapSaki is a predictor of mortality in critically ill patients with acute kidney injury. 
Clin Chem. 2015; 61(1):191-201.

Kleimann A, Toto S, Eberlein CK, Kielstein JT, Bleich S, Frieling H, Sieberer M.
Psychiatric symptoms in patients with Shiga toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome. 
PLoS One. 2014;9(7):e101839.

Molnar MZ, Kümpers P, Kielstein JT, Schiffer M, Czira ME, Ujszaszi A, Kovesdy CP, Mucsi I.
Circulating Angiopoietin-2 levels predict mortality in kidney transplant recipients: a 4-year prospective case-cohort study.
Transpl Int. 2014;2 7(6):541-52.

Schramek GG, Stoevesandt D, Reising A, Kielstein JT, Hiss M, Kielstein H.
Imaging in anatomy: a comparison of imaging techniques in embalmed human cadavers. 
BMC Med Educ. 2013;13:143.

Hoeper MM, Wiesner O, Hadem J, Wahl O, Suhling H, Duesberg C, Sommer W, Warnecke G, Greer M, Boenisch O, Busch M, Kielstein JT, Schneider A, Haverich A, Welte T, Kühn C.
Extracorporeal membrane oxygenation instead of invasive mechanical ventilation in patients with acute respiratory distress syndrome.
Intensive Care Med. 2013; 39(11):2056-7.

Ge S, Hertel B, Koltsova EK, Sörensen-Zender I, Kielstein JT, Ley K, Haller H, von Vietinghoff S.
Increased atherosclerotic lesion formation and vascular leukocyte accumulation in renal impairment are mediated by interleukin-17A. 
Circ Res. 2013; 113(8):965-74.

Lukasz A, Beutel G, Kümpers P, Denecke A, Westhoff-Bleck M, Schieffer B, Bauersachs J, Kielstein JT, Tutarel O.
Angiopoietin-2 in adults with congenital heart disease and heart failure. 
PLoS One. 2013; 8(6):e66861.

Worthmann H, Martens-Lobenhoffer J, Joumaah M, Li N, Lichtinghagen R, Hecker H, Kielstein JT, Ehrenreich H, Bode-Böger SM, Weissenborn K.
Asymmetric dimethylarginine in response to recombinant tissue-type plasminogen activator and erythropoietin in acute stroke. 
Stroke. 2013;44(8):2128-33.

Weissenborn K, Bültmann E, Donnerstag F, Giesemann AM, Götz F, Worthmann H, Heeren M, Kielstein JT, Schwarz A, Lanfermann H, Ding XQ.
Quantitative MRI shows cerebral microstructural damage in hemolytic-uremic syndrome patients with severe neurological symptoms but no changes in conventional MRI. 
Neuroradiology. 2013; 55(7):819-25.

 

III Reviews / Editorials / Letter

Schmitz M, Joannidis M, Czock D, John S, Jörres A, Klein SJ, Oppert M, Schwenger V, Kielstein JT, Zarbock A, Kindgen-Milles D, Willam C.
Regionale Zitratantikoagulation bei Nierenersatzverfahren auf der Intensivstation. 
Med Klin Intensivmed Notfmed. 2018;113(5):377-383.

Druml W, Joannidis M, John S, Jörres A, Schmitz M, Kielstein JT, Kindgen-Milles D, Oppert M, Schwenger V, Willam C, Zarbock A.
Metabolische Führung und Ernährung von Intensivpatienten mit renaler Dysfunktion. 
Med Klin Intensivmed Notfmed. 2018;113(5):393-400.

Joannidis M, Klein SJ, John S, Schmitz M, Czock D, Druml W, Jörres A, Kindgen-Milles D, Kielstein JT, Oppert M, Schwenger V, Willam C, Zarbock A.
Prävention der akuten Nierenschädigung beim kritisch kranken Patienten. 
Med Klin Intensivmed Notfmed. 2018;113(5):358-369.

Czock D, Schwenger V, Kindgen-Milles D, Joannidis M, John S, Schmitz M, Jörres A, Zarbock A, Oppert M, Kielstein JT, Willam C.
Dosierung von Antiinfektiva bei Nierenversagen und Nierenersatztherapie in der Intensivmedizin. 
Med Klin Intensivmed Notfmed. 2018 Jun;113(5):384-392.

Druml W, Czock D, Klein SJ, Oppert M, Schmitz M, Kielstein JT, Zarbock A, Joannidis M, John S.
Extrakorporale Nierenersatztherapie bei akuter Nierenschädigung. Med Klin Intensivmed Notfmed. 2018;113(5):370-376.

Friesecke S, Träger K, Schittek GA, Molnar Z, Bach F, Kogelmann K, Bogdanski R, Weyland A, Nierhaus A, Nestler F, Olboeter D, Tomescu D, Jacob D, Haake H, Grigoryev E, Nitsch M, Baumann A, Quintel M, Schott M, Kielstein JT, Meier-Hellmann A, Born F, Schumacher U, Singer M, Kellum J, Brunkhorst FM.
International registry on the use of the CytoSorb® adsorber in ICU patients : Study protocol and preliminary results.
Med Klin Intensivmed Notfmed. 2017. doi: 10.1007/s00063-017-0342-5.

Vanmassenhove J, Kielstein JT, Jörres A, Biesen WV.
Management of patients at risk of acute kidney injury. 
Lancet. 2017; 389(10084):2139-2151.

Kielstein JT, Kruse AK, Anderson N, Vaitiekunas H, Scherneck S.
Boliden auf der Intensivstation. Wie viel Antibiotika verbraucht Ihre Nierenersatztherapie pro Tag? 
Med Klin Intensivmed Notfmed. 2017, doi: 10.1007/s00063-017-0303-z.

Vanmassenhove J, Kielstein JT, Ostermann M.
Have renal biomarkers failed in acute kidney injury? Yes.
Intensive Care Med. 2017;43(6):883-886.

Hafer C, Kielstein JT.
Pro: High dose of therapeutic plasma exchange-mind the gap! 
Nephrol Dial Transplant. 2017;32(9):1457-1460.

Boser M, Kielstein JT.
Role of plasmapheresis and immunoadsorption in salvage therapy of rheumatological diseases. 
Z Rheumatol. 2016;75(10):964-972.

Kielstein JT, Schmidt JJ.
Ceftolozane-tazobactam versus levofloxacin in urinary tract infection. 
Lancet. 2015; 386(10000):1241.

Schneider SM, Kielstein JT, Braverman J, Novak M.
Cognitive Function in Patients With Chronic Kidney Disease: Challenges in Neuropsychological Assessments. 
Semin Nephrol. 2015; 35(4):304-10.

Auschra C, Kielstein JT, Tecklenburg A, Müller-Seitz G.
After the crisis is before the crisis: Coping-strategies for public health emergency situations on different levels--experiences of the German E. coli outbreak 2011. 
MMW Fortschr Med. 2014; Suppl 4:115-9.

Borghi C, Rosei EA, Bardin T, Dawson J, Dominiczak A, Kielstein JT, Manolis AJ, Perez-Ruiz F, Mancia G.
Serum uric acid and the risk of cardiovascular and renal disease. 
J Hypertens. 2015; 33(9):1729-41.

Schmidt JJ, Kielstein JT.
Three shades of fluids: Bergström 2.0 / Furosemide stress test / replacement fluid for therapeutic plasma exchange. 
Dtsch Med Wochenschr. 2015; 140(12):897-9.

Juurlink DN, Gosselin S, Kielstein JT, Ghannoum M, Lavergne V, Nolin TD, Hoffman RS; EXTRIP Workgroup.
Extracorporeal Treatment for Salicylate Poisoning: Systematic Review and Recommendations From the EXTRIP Workgroup. 
Ann Emerg Med. 2015;66(2):165-81.

Sellin L, Kielstein JT, de Groot K.
Hyperuricemia - more than gout : Impact on cardiovascular risk and renal insufficiency.
Z Rheumatol. 2015;74(4):322-8.

Schmidt JJ, Beutel G, Kielstein JT.
Diagnosis and pathophysiology of acute renal failure . is prevention possible? 
Dtsch Med Wochenschr. 2015;140(4):245-9.

Gosselin S, Juurlink DN, Kielstein JT, Ghannoum M, Lavergne V, Nolin TD, Hoffman RS; Extrip Workgroup.
Extracorporeal treatment for acetaminophen poisoning: recommendations from the EXTRIP workgroup. 
Clin Toxicol (Phila). 2014; 52(8):856-67.

Kielstein JT.
The deadly sins of pharmacotherapy in chronic kidney disease. 
MMW Fortschr Med. 2014;156(7):38-40.

Lavergne V, Ouellet G, Bouchard J, Galvao T, Kielstein JT, Roberts DM, Kanji S, Mowry JB, Calello DP, Hoffman RS, Gosselin S, Nolin TD, Goldfarb DS, Burdmann EA, Dargan PI, Decker BS, Hoegberg LC, Maclaren R, Megarbane B, Sowinski KM, Yates C, Mactier R, Wiegand T, Ghannoum M.
Guidelines for reporting case studies on extracorporeal treatments in poisonings: methodology.
Semin Dial. 2014; 27(4):407-14.

Kielstein JT.
Drug dosing in extracorporeal therapy. 
Med Klin Intensivmed Notfmed. 2014;109(5):348-53.

Schepers E, Speer T, Bode-Böger SM, Fliser D, Kielstein JT.
Dimethylarginines ADMA and SDMA: the real water-soluble small toxins? 
Semin Nephrol. 2014;34(2):97-105.

Kielstein JT.
Glucose levels and risk of dementia. 
N Engl J Med.; 369(19):1863.

Kielstein JT, David S.
Pro: Renal replacement trauma or Paracelsus 2.0. 
Nephrol Dial Transplant. 2013;28(11):2728-31.

Kielstein JT, Bernstein HG.
The reversible part of cognitive impairment in chronic kidney disease: can mice help men break the TEMPOLimit? 
Nephrol Dial Transplant. 2014; 29(3):476-8.

Worthmann H, Kielstein JT, Weissenborn K.
Response to letter regarding article, "Asymmetric dimethylarginine in response to recombinant tissue-type plasminogen activator and erythropoietin in acute stroke". 
Stroke. 2013;44(12):e230.

Beutel G, Kielstein JT, Ganser A.
Thrombotic microangiopathy. 
Internist (Berl). 2013; 54(9):1070-9.

Rissland J, Kielstein JT, Stark K, Wichmann-Schauer H, Stümpel F, Pulz M.
The EHEC O104:H4 outbreak in Germany 2011 - lessons learned?! 
Gesundheitswesen. 2013; 75(4):184-9.

 

IV Case Reports

Eden G, Kühn-Velten WN, Hafer C, Kielstein JT.
Enhanced elimination of cyclophosphamide by high cut-off haemodialysis: single-dose pharmacokinetics in a patient with cast nephropathy. 
BMJ Case Rep.2018. pii: bcr-2017-221735.

Einecke G, Beutel G, Hoeper MM, Kielstein JT.
The answer is blowing in the wind: an uncommon cause for severe ARDS accompanied by circulatory insufficiency requiring extracorporeal membrane oxygenation. 
BMJ Case Rep. 2017; pii: bcr2016218079. doi: 10.1136/bcr-2016-218079.

Hansen-Hagge C, Bräsen JH, Kielstein JT
Akute Nierenschädigung durch intravenöse Immunglobuline – eine vermeidbare Komplikation. 
Z Rheumatol. 2017;76(3):279-280. doi: 10.1007/s00393-017-0273-9.

David S, Thamm K, Schmidt BMW, Falk CS, Kielstein JT.
Effect of extracorporeal cytokine removal on vascular barrier function in a septic shock patient. 
J Intensive Care. 2017; 5:12.

Eden G, Gradaus F, Brown K, Gauert I, Sass C, Kielstein JT.
Plasmapherese zur Behandlung einer hypertriglyzeridämiebedingten Pankreatitis. 
Med Klin Intensivmed Notfmed. 2017;112(5):471-474.

Schmidt JJ, Bode-Böger SM, Wilhelmi M, Omar M, Martens-Lobenhoffer J, Welte T, Kielstein JT.
Pharmacokinetics and total removal of fosfomycin in two patients undergoing intermittent haemodialysis and extended dialysis: prescription needs to avoid under-dosing. 
J Antimicrob Chemother. 2016;71(9):2673-4.

Arelin V, Schmidt JJ, Kayser N, Kühn-Velten WN, Suhling H, Eden G, Kielstein JT.
Removal of methadone by extended dialysis using a high cut-off dialyzer: implications for the treatment of overdose and for pain management in patients undergoing light chain removal. 
Clin Nephrol. 2016;85(6):353-7.

Schmidt JJ, Ramazan L, Bockemeyer C, Günter HH, Martens-Lobenhoffer J, Ganzenmüller T, Bode-Böger SM, Kielstein JT.
Acute interstitial nephritis due to flecainide therapy in the 38(th) week of pregnancy. 
BMC Nephrol. 2016; 17:28.

Schmidt JJ, Bertram A, Kühn-Velten WN, Suhling H, Wiesner O, Schneider A, Kielstein JT.
Treatment of amitriptyline intoxications by extended high cut-off dialysis. 
Clin Kidney J. 2015; 8(6):796-9.

David S, Hoeper MM, Kielstein JT.
Plasma exchange in treatment refractory septic shock: Presentation of a therapeutic add-on strategy. 
Med Klin Intensivmed Notfmed. 2017;112(1):42-46.

Strunk AK, Ciesek S, Schmidt JJ, Kühn C, Hoeper MM, Welte T, Kielstein JT.
Single- and multiple-dose pharmacokinetics of ethambutol and rifampicin in a tuberculosis patient with acute respiratory distress syndrome undergoing extended daily dialysis and ECMO treatment. 
Int J Infect Dis. 2016; 42:1-3.

Drick N, Patecki M, Arelin V, Schmidt JJ, Wahl O, Kielstein JT.
Successful hemodialysis for life-threatening carbamazepine drug overdose: Case-based introduction of new guidelines. 
Med Klin Intensivmed Notfmed. 2015; 110(7):551-4.

Baroke E, Schmidt JJ, Strunk AK, Wiesner O, Kühn-Velten WN, Kielstein JT.
Saving two lives with one dialysis treatment. 
Clin Nephrol. 2015; 84(2):104-7.

Schmidt JJ, Lorenzen J, Chatzikyrkou C, Lichtinghagen R, Kielstein JT.
Total collected dialysate lithium concentration after successful dialysis treatment in case of intoxication. 
BMC Pharmacol Toxicol. 2014;15:49. doi: 10.1186/2050-6511-15-49.

Bahte SK, Hiss M, Lichtinghagen R, Kielstein JT.
A missed opportunity - consequences of unknown levetiracepam pharmacokinetics in a peritoneal dialysis patient. 
BMC Nephrol. 2014;15:49.

Strunk AK, Schmidt JJ, Baroke E, Bode-Böger SM, Martens-Lobenhoffer J, Welte T, Kielstein JT.
Single- and multiple-dose pharmacokinetics and total removal of colistin in a patient with acute kidney injury undergoing extended daily dialysis.
J Antimicrob Chemother. 2014; 69(7):2008-10.

Bertram A, Haenel SS, Hadem J, Hoeper MM, Gottlieb J, Warnecke G, Kaschinski S, Hafer C, Kühn-Velten WN, Günther D, Kielstein JT.
Tissue concentration of paraquat on day 32 after intoxication and failed bridge to transplantation by extracorporeal membrane oxygenation therapy. 
BMC Pharmacol Toxicol. 2013;14:45.

Clajus C, Kühn-Velten WN, Schmidt JJ, Lorenzen JM, Pietsch D, Beutel G, Kielstein JT.
Cotrimoxazole plasma levels, dialyzer clearance and total removal by extended dialysis in a patient with acute kidney injury: risk of under-dosing using current dosing recommendations. 
BMC Pharmacol Toxicol. 2013; 14:19.

 

V Book chapter

Kielstein JT.
„Nephrologie“
in Jahn / van Aken „Zusatzweiterbildung Intensivmedizin“
Georg Thieme Verlag 3. unveränderte Auflage 2017
ISBN: 9783132406148.

Kielstein JT.
“Harnsäuresenkung beim niereninsuffizienten Patienten: mit Hyperurikämie: Laborkosmetik oder pathophysiologisch sinnvolle Therapie?“
in Rieke & Manger „Gicht“ Der aktuelle Wissensstand zu Ätiologie, Pathogenese, Diagnostik, Klinik und Therapie
De Gruyter 2016
ISBN 978-3-11-045138-2.

Kielstein JT. 
"Drug prescription in chronic kidney disease"
in Arici “Management of Chronic Kidney Disease, A Clinician's Guide, 2014”, Springer 2014
ISBN 9783642546372.

Hiss M & Kielstein JT.
“Chronic kideny disease”
in Merseburger, Kuczyk, Moul, „Urology at a glance“
Springer 2014
ISBN 978-3-642-54859-8.

Hiss M & Kielstein JT.
“Acute kidney injury”
in Merseburger, Kuczyk, Moul, „Urology at a glance“
Springer 2014
ISBN 978-3-642-54859-8.

Kielstein JT. 
“Niere und Harnsäure – eine wechselseitige Beeinflussung”
in Tausche “Gicht - neue Aspekte zur Pathogenese, Diagnostik und Therapie.” Unimed Verlag 2014
ISBN 9783837422825.